| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059917 Vitamin d3 and analogs thereof for treating alopecia |
| 03/10/2011 | US20110059915 Purine derivatives and methods of use thereof |
| 03/10/2011 | US20110059907 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059891 Alpha-msh therapies for treatment of autoimmune disease |
| 03/10/2011 | US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059192 Methods and Compositions for Modulating Hair Growth or Regrowth |
| 03/10/2011 | US20110059191 Bcl-2 protein expressing agent, apoptosis inhibiting agent and agent for preventing ultraviolet dna damage of epidermal cell |
| 03/10/2011 | US20110059182 Spraying device and related method for cell aggregates and cell aggregate suspension thereof |
| 03/10/2011 | US20110059173 encoding a polypeptide comprising a carboxy-terminal amino acid sequence of an alpha Connexin; reduces scar formation |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059095 High affinity human antibodies to human protease-activated receptor-2 |
| 03/10/2011 | US20110059084 Agent for treating disease |
| 03/10/2011 | US20110059083 Agent for treating disease |
| 03/10/2011 | US20110059082 Agent for treating disease |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059057 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/10/2011 | US20110059028 Method for membrane electrolysis and the use of the products obtained by it |
| 03/10/2011 | CA2772992A1 Use of non-digestible oligosaccharides |
| 03/10/2011 | CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292737A1 Use of adipose tissue-derived stromal stem cells in treating fistula |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292593A2 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 03/09/2011 | EP2292592A1 Sulfonamide compound and application thereof |
| 03/09/2011 | EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use |
| 03/09/2011 | EP2292588A1 Ceramide dimers and their use as medicine or cosmetic preparation |
| 03/09/2011 | EP2292301A2 Anti-interferon-alpha antibodies |
| 03/09/2011 | EP2292235A2 Methotrexate solutions |
| 03/09/2011 | EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 03/09/2011 | EP2292226A2 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 03/09/2011 | EP2292091A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 03/09/2011 | EP2291180A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 03/09/2011 | EP2291179A2 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative |
| 03/09/2011 | EP1778833B1 Methods of using regenerative cells to promote wound healing |
| 03/09/2011 | EP1513793B1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | CN101984036A Health vinegar and preparation method thereof |
| 03/09/2011 | CN101983705A Traditional Chinese medicine for treating diabetic acra necrosis |
| 03/09/2011 | CN101983703A Traditional Chinese medicine composition and traditional Chinese medicine preparation |
| 03/09/2011 | CN101983693A Drug for treating alopecia and preparation method thereof |
| 03/09/2011 | CN101983683A Traditional Chinese medicine for treating diabetic pruritus |
| 03/09/2011 | CN101983678A Pharmaceutical composition for accelerating wound healing and preparation method thereof |
| 03/09/2011 | CN101983661A Traditional Chinese medicine for treating psoriasis |
| 03/09/2011 | CN101983660A Chinese traditional medicine composition for enriching blood and beautifying face and preparation method thereof |
| 03/09/2011 | CN101983651A Medicine for treating beriberi and preparation method thereof |
| 03/09/2011 | CN101983650A Medicament for treating dermatitis aestivale |
| 03/09/2011 | CN101983649A Method for preparing traditional Chinese medicine tincture for curing leucoderma |
| 03/09/2011 | CN101274049B Medicament for curing multiple traumas |
| 03/09/2011 | CN101060828B Surfactant composition |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902208 Treating allergic and inflammatory conditions |
| 03/08/2011 | US7902164 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901894 Kinase inhibitors |
| 03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 03/08/2011 | US7901698 Pharmaceutical compositions comprising silicones and two solubilized active principles |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2483764C Arsenic therapy for apls-type autoimmune lymphoproliferative syndrome in mice and humans |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2361251C Formulations comprising antisense nucleotides to connexins |
| 03/03/2011 | WO2011026094A2 Stable aerosol topical foams comprising a hypochlorite salt |
| 03/03/2011 | WO2011026076A2 Topical formulations comprising a steroid |
| 03/03/2011 | WO2011025635A2 Cosmetic uses of modified stressed yeast extracts and related compositions |
| 03/03/2011 | WO2011025107A1 Composition for relieving pruritus |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024942A1 Matrix metalloprotease-2 (mmp-2) inhibitor |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024620A1 Antimycotic pharmaceutical composition |
| 03/03/2011 | WO2011024027A1 Pharmaceutical combinations of diflucortolone and terbinafine |
| 03/03/2011 | WO2011023287A1 Use of faa and its derivatives in cosmetics and dermatology |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2011023013A1 Medicine for dissolving and eliminating wart and excrescence consisting of protein and its uses |
| 03/03/2011 | WO2011022757A1 Purine-targeted diagnosis and therapy of wounds |
| 03/03/2011 | WO2011005406A3 Skin repair compositions comprising circadian gene activators and a synergistic combination of sirt1 gene activators |
| 03/03/2011 | WO2011003858A3 Pharmaceutical compositions and solid forms |
| 03/03/2011 | WO2010120691A3 Methionine sulfoxide peptide, compositions and methods of use |
| 03/03/2011 | WO2010117199A3 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | US20110054375 Dressing comprising polyacrylate particles and use thereof |
| 03/03/2011 | US20110054039 Use of alkyl sulfates or sulfonates against propionibacterium acnes |
| 03/03/2011 | US20110054016 Method for modulating claudin mediated functions |
| 03/03/2011 | US20110054004 Method for reducing scarring during wound healing using antisense compounds directed to ctgf |
| 03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053976 Quinoline derivatives and their use as tyrosine kinase inhibitors |